NO146598C - Analogifremgangsmaate for fremstilling av det terapeutisk aktive n-(1`-allyl-2`-pyrrolidylmetyl)-2,3-dimetoksy-5-sulfamoylbenzamider og derivater derav - Google Patents

Analogifremgangsmaate for fremstilling av det terapeutisk aktive n-(1`-allyl-2`-pyrrolidylmetyl)-2,3-dimetoksy-5-sulfamoylbenzamider og derivater derav

Info

Publication number
NO146598C
NO146598C NO772530A NO772530A NO146598C NO 146598 C NO146598 C NO 146598C NO 772530 A NO772530 A NO 772530A NO 772530 A NO772530 A NO 772530A NO 146598 C NO146598 C NO 146598C
Authority
NO
Norway
Prior art keywords
dimetoxy
pyrrolidylmethyl
benzamides
sulfamoyl
allyl
Prior art date
Application number
NO772530A
Other languages
English (en)
Norwegian (no)
Other versions
NO772530L (no
NO146598B (no
Inventor
Michel Leon Thominet
Jacques Perrot
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of NO772530L publication Critical patent/NO772530L/no
Publication of NO146598B publication Critical patent/NO146598B/no
Publication of NO146598C publication Critical patent/NO146598C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO772530A 1976-07-19 1977-07-15 Analogifremgangsmaate for fremstilling av det terapeutisk aktive n-(1`-allyl-2`-pyrrolidylmetyl)-2,3-dimetoksy-5-sulfamoylbenzamider og derivater derav NO146598C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7622180A FR2358892A1 (fr) 1976-07-19 1976-07-19 N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives

Publications (3)

Publication Number Publication Date
NO772530L NO772530L (no) 1978-01-20
NO146598B NO146598B (no) 1982-07-26
NO146598C true NO146598C (no) 1982-11-03

Family

ID=9175947

Family Applications (1)

Application Number Title Priority Date Filing Date
NO772530A NO146598C (no) 1976-07-19 1977-07-15 Analogifremgangsmaate for fremstilling av det terapeutisk aktive n-(1`-allyl-2`-pyrrolidylmetyl)-2,3-dimetoksy-5-sulfamoylbenzamider og derivater derav

Country Status (38)

Country Link
US (1) US4499019A (xx)
JP (1) JPS5338631A (xx)
AR (1) AR214330A1 (xx)
AT (1) AT365570B (xx)
AU (1) AU509291B2 (xx)
BE (1) BE856289A (xx)
CH (1) CH627162A5 (xx)
CS (1) CS219885B2 (xx)
CY (1) CY1036A (xx)
DD (2) DD132492A5 (xx)
DK (1) DK156646C (xx)
EG (1) EG12911A (xx)
ES (1) ES460621A1 (xx)
FI (1) FI67213C (xx)
FR (1) FR2358892A1 (xx)
GB (1) GB1539319A (xx)
GR (1) GR60836B (xx)
HK (1) HK17880A (xx)
HU (1) HU174981B (xx)
IE (1) IE46171B1 (xx)
IL (1) IL52547A (xx)
IN (1) IN146993B (xx)
LU (1) LU77782A1 (xx)
MC (1) MC1153A1 (xx)
MX (1) MX4711E (xx)
NL (1) NL174347C (xx)
NO (1) NO146598C (xx)
NZ (1) NZ184634A (xx)
OA (1) OA05704A (xx)
PH (1) PH12838A (xx)
PL (1) PL104244B1 (xx)
PT (1) PT66819B (xx)
RO (1) RO71691A (xx)
SE (1) SE425243B (xx)
SU (1) SU695556A3 (xx)
YU (1) YU40677B (xx)
ZA (1) ZA774256B (xx)
ZM (1) ZM5477A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
JPS5639431A (en) * 1979-09-06 1981-04-15 Susumu Yagyu Colorimeter having two-light pass length and two-wave length
FR2478093A1 (fr) * 1980-03-12 1981-09-18 Ile De France Nouveau procede de preparation de n-(1-alkyl (ou allyl) 2-pyrrolidinyl-methyl)2-methoxy (ou 2,3-dimethoxy) 5-sulfamoyl (ou sulfamoyl substitue)
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
US8420624B2 (en) * 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
CN105481733A (zh) * 2015-12-30 2016-04-13 苏州诚和医药化学有限公司 一种一步法合成2-甲氧基-5-氨磺酰基苯甲酸甲酯的方法

Also Published As

Publication number Publication date
AU2702677A (en) 1979-01-18
PH12838A (en) 1979-09-05
ES460621A1 (es) 1978-05-01
OA05704A (fr) 1981-05-31
IN146993B (xx) 1979-10-20
NL174347B (nl) 1984-01-02
NL174347C (nl) 1984-06-01
YU173977A (en) 1983-01-21
FR2358892B1 (xx) 1978-12-15
NZ184634A (en) 1978-11-13
IE46171B1 (en) 1983-03-23
EG12911A (en) 1980-12-31
BE856289A (fr) 1977-12-30
MX4711E (es) 1982-08-11
NO772530L (no) 1978-01-20
US4499019A (en) 1985-02-12
DK326377A (da) 1978-01-20
LU77782A1 (xx) 1977-10-17
IL52547A0 (en) 1977-10-31
PL104244B1 (pl) 1979-08-31
NO146598B (no) 1982-07-26
CY1036A (en) 1980-08-01
DD132492A5 (de) 1978-10-04
YU40677B (en) 1986-04-30
ATA511677A (de) 1981-06-15
SU695556A3 (ru) 1979-10-30
FI772214A (xx) 1978-01-20
CS219885B2 (en) 1983-03-25
GB1539319A (en) 1979-01-31
PT66819A (fr) 1977-08-01
NL7707982A (nl) 1978-01-23
ZM5477A1 (en) 1978-05-22
ZA774256B (en) 1978-06-28
GR60836B (en) 1978-08-31
AR214330A1 (es) 1979-05-31
SE425243B (sv) 1982-09-13
MC1153A1 (fr) 1978-04-17
JPS5338631A (en) 1978-04-08
DK156646C (da) 1990-02-05
JPS554724B2 (xx) 1980-01-31
FR2358892A1 (fr) 1978-02-17
FI67213C (fi) 1985-02-11
PT66819B (fr) 1978-12-22
DD137670A5 (de) 1979-09-19
IL52547A (en) 1980-01-31
DK156646B (da) 1989-09-18
IE46171L (en) 1978-01-19
SE7708176L (sv) 1978-01-20
FI67213B (fi) 1984-10-31
HK17880A (en) 1980-04-11
RO71691A (ro) 1982-09-09
AT365570B (de) 1982-01-25
PL199723A1 (pl) 1978-04-24
AU509291B2 (en) 1980-05-01
CH627162A5 (xx) 1981-12-31
HU174981B (hu) 1980-04-28

Similar Documents

Publication Publication Date Title
NO803259L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenaminderivater
NO148643C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye 1-(1,3-dixolan-2-ylmetyl)-1h-imidazoler og-1h-1,2,4-triazoler
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
SE428126B (sv) Forfarande att framstella terapeutiskt aktiva 3-pyrrolidinyl-alfa,alfa-difenylacetamider och 3-pyrrolidinyl-alfa,alfa-difenylmetaner
PH16512A (en) N-(phenylalkylamino-alkyl)-dihydroisoquinolinones,pharmaceutical compositions and methods employing them
NO148416C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-, morfolin- og tiazan-derivater
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
NO821851L (no) 6,61-oksybis-halogensubstituert-pyron-derivater og fremgangsmaate for fremstilling derav
NO146598C (no) Analogifremgangsmaate for fremstilling av det terapeutisk aktive n-(1`-allyl-2`-pyrrolidylmetyl)-2,3-dimetoksy-5-sulfamoylbenzamider og derivater derav
FR2340312A1 (fr) N-(1,3,4-thiadiazol-2-yl) benzamides insecticides
NO145793C (no) Analogifremgangsmaate for fremstilling av den fysiologisk aktive forbindelse n-(r-tetrahydrofurfuryl)-noroksymorfon
IT1123915B (it) N-(1,2,4-triazin-5-on-4-il)-glicin-derivati,procedimento per la loro preparazione e loro impiego come erbicidi
NO152971C (no) Analogifremgangsmaate for fremstilling av n-(1-metyl-2-pyrrolidinyl-metyl)-2,3-dimetoksy-5-metylsulfamoyl-benzamid og derivater derav.
NO165999C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-(2-aminoetyl)benzamid-derivater.
NO147108C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 1-amino-lavere-alkyl-3,4-difenyl-1h-pyrazoler
NO145436C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminer.
NO141314C (no) Analogifremgangsmaate ved fremstilling av det terapeutisk aktive n-(1`-allylpyrrolidinyl-2`-methyl)-2-methoxy-4,5-azimidobenzamid
NO146061C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive derivater av 2-iminothiazolidiner og 2-iminothiazoliner
FR2342064A1 (fr) Benzamides 2,5 disubstitues, leurs procedes de preparation et leurs applications therapeutiques
NO772739L (no) Fremgangsm}te til fremstilling av nye, substituerte 2,3-alkylen-bis(oksy)benzamider og deres derivater
NO145274C (no) Fremgangsmaate for fremstilling av et 1-benzoyl-2-(2`,6`-diklorfenylamino)-2-imidazolin og av deres salter
BE869674A (fr) N-(1,3,4-thiadiazol-2-yl)benzamides insecticides
DD127852A5 (de) Insektizide,akarizide und nematizide
BE856485A (fr) (2-azabicyclo(2.2.2)octane-2-yl) diphenylalcanones et derives et leur preparation et leurs utilisations therapeutiques